Philip Westgate News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Research led by Dr. Philip Kern was highlighted by the National Institute of Diabetes and Digestive and Kidney Diseases.
LEXINGTON, Ky. (June 2, 2021) – Research led by University of Kentucky endocrinologist and Center for Clinical & Translational Science director Dr. Philip Kern was recently highlighted by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) in its 2021 Recent Advances & Emerging Opportunities report. The publication conveys important accomplishments resulting from NIDDK-funded research, as well as the enormous promise this research holds for the future.
Kern’s research demonstrated for the first time that a medication called mirabegron, already FDA-approved to treat overactive bladder, improves multiple measures of glucose metabolism in people who are overweight/obese with insulin resistance by inducing beige fat formation in their white adipose fat tissue. The findings uncover a potential new mechanism for treatment of diab ....

United Kingdom , Hasiyet Memetimin , Jianzhong Chen , Brian Finlin , Andrew Morris , Esthere Dupont Versteegden , Beibei Zhu , Hemendra Vekaria , Zacharyr Johnson , Philip Westgate , Riham El Khouli , National Institute Of Diabetes , United Kingdom Markey Cancer Center , College Of Health Sciences , College Of Public Health , Saha Cardiovascular Research Center , College Of Medicine , Health You , University Of Kentucky , Translational Science , National Institute , Kidney Diseases , Emerging Opportunities , Markey Cancer , Amy Confides , Health Sciences ,